A study published this month in Science discusses data that may support a devious alter ego of T-cells present within colorectal cancer tumors.
Tag Archive for: CRISPR
DEM BioPharma, backed by an impressive list of investors, debuted Thursday with $70 million that will assist in its efforts to treat cancer with an approach that leverages CRISPR screening and macrophage biology in immuno-oncology.